Are you seeking opportunities to learn or grow professionally? Do you have specific eye and vision science topics that you want to explore more deeply?
ARVOLearn — the online learning system from ARVO — combines the latest advances in online learning with the expertise and knowledge of the world’s largest eye and vision research organization. Whether you want session presentations from recent ARVO meetings, an on-demand course or a series of modules or mini modules that you can view at your convenience, ARVOLearn can help you expand your knowledge and grow your career.
Access to ARVOLearn
Members
ARVO members have access to the ARVOLearn media library and select modules as part of their membership. Members can use their current ARVO credentials to log in to ARVOLearn.
Nonmembers
Access to the Annual Meeting session recordings within ARVOLearn can be purchased through a subscription option. Individual learning activities can be purchased at the nonmember rate. Browse the catalog.
Conference content available in ARVOLearn
ARVO 2020 & Imaging Conference online presentations (please visit the 2021 ARVO Annual meeting platform for current conference content)
Access Pass
Pass subscriptions offer one year of access to the ARVOLearn media library catalog containing hundreds of video presentations from recent ARVO Annual Meetings. On-demand course access is available for a separate a la carte fee. Learn more about the Access Pass on ARVOLearn. ARVO members can log in with their current ARVO username/password. Nonmembers can create an account.Learn more
Please note that an Access Pass is not considered membership to ARVO. An ARVO membership is not required to purchase an Access Pass to the ARVOLearn media library. However, an ARVO membership is required to submit an abstract to ARVO’s Annual Meeting and to receive other member benefits.
Upcoming events
Don't miss out! Secure your spot for the following events:
Oct. 6 (8 - 9am ET): Long distance relationships in science - How to keep the flame alive
Cost: Free
During the COVID-19 pandemic, researchers have needed to rely on virtual technologies to continue their scientific research. Technology-mediated communication offers not only a vital, but exciting, opportunity for collaborating and educating scholars as well as combating the impacts of this pandemic, through virtual communication. Hosted by ARVO's Global Members Committee, attendees of this webinar will learn:
- The importance of virtual collaboration
- How to run an efficient virtual collaboration
- How to inform participants about various tools for collaboration and education
Oct. 27 - 29: Health Economics and Outcomes Research Conference
Cost: MIT $39, Members $89, Nonmembers $129
This virtual conference addresses the needs of investigators seeking to collect and analyze health economic evaluation data, to develop and assess patient reported outcome measures, to evaluate treatment options for ophthalmic diseases and disorders and to design clinical trials. Participants will be able to:
- Discuss the fundamental principles of health economic (HE) evaluation and the measurement of patient-reported outcomes (PROMs)
- Explain the results of HE evaluations and PROMs published in peer-reviewed literature
- Identify a well-formulated HEOR research question and the data needed to answer it.
- Describe the design and execution of several HE evaluation and PROMs research projects
- Summarize how patients can contribute to the research design process
Nov. 3 (12-1pm ET): Impact of the COVID-19 pandemic on vision research: Reflections and lessons learned
Cost: Free
This webinar will focus on lessons-learned from managing a lab during the COVID-19 pandemic. Hear from Stephen H. Tsang, MD, PhD, as he discusses his clinical experience with COVID-19 and how that knowledge impacts working in the lab. Following Dr. Tsang's presentation, listen to a panel of experts from the U.S., Europe and India as they discuss regional perspectives of the impact of the COVID-19 pandemic on basic science. The webinar concludes by the panel addressing questions from the live audience.Professional development and education committee (PDEC) webinar.
Attendees of this webinar will:
- Learn the “dos” and “don’ts” of managing a lab during a shutdown
- Hear lessons-learned from the Covid-19 pandemic from a panel of vision research experts
On-demand events
Select the titles below to learn more and purchase. Visit ARVOLearn for access to more on-demand offerings.
Getting the most from Big Data Sets
Cost: MIT $39, Members $89, Nonmembers $129
The goldmine of research data that ophthalmology offers about vision pathways and the prevention and treatment of eye disease is still out of reach to the average investigator. Sessions from this three-day virtual conference will provide you with strategies from leading experts in the field of big data in ophthalmology on how to gain access, analyze and become an expert in using Big Data Sets in your research. Michael F. Chiang, MD, incoming director of NIH's National Eye Institute (NEI), leads off this event with the featured presentation.
Bench to Bedside (B2B) webinar series
Cost: Free (available to members)
Sign up for this three-part educational series that tackles the following need-to-know topics for eye and vision science innovators:
- Raising Funds and Working as a Virtual Company
- Intellectual Property and Technology Transfer
- Regulatory Considerations
Behind the success: Best practices for building a Team Science research project
Cost: MIT $55, Members $89, Nonmembers $129
Access this virtual conference to hear how your colleagues have designed and executed large collaborative basic and clinical research projects. Attendees will learn about managing large collaborative teams, gain insights from long-standing and successful global collaborations, explore large multicenter clinical research and trials, plus much more.
On-demand courses
Select the titles below to learn more and purchase. Visit ARVOLearn for access to more on-demand offerings.
Stem cells in ophthalmology
Cost: MIT $49, Members $79, Nonmembers $109
Effective application of stem cells in research, drug/cell therapy development and clinical practice require an understanding of the capacities, complexities and potential of different stem cell types relative to the biology of the eye and eye diseases. This course will clarify the current and future utility of stem cells ophthalmology, by defining key stem cell terminologies, concepts and applications that relate to the cornea, lens and retina-including through the use of historical and contemporary examples. This course includes on-demand presentations with a live panel discussion.
Night Vision in Aging, AMD and Beyond
Cost: MIT $49, Members $79, Nonmembers $109
An important characteristic of vision in aging and AMD is that rod photoreceptors are affected earlier and more severely than are cones. Clinicians can take advantage of new technology in testing rod function as an early indicator of macular disease and new knowledge on the outer neurovascular unit in interpreting clinical imaging- specifically, how the presence and distribution of rods and the comparative vision of rods and cones can be used to dissect mechanisms. In turn, better knowledge of visual function and explanatory hypotheses that are well-supported in human biology can drive development of rapid and non-invasive imaging tests. This course will demonstrate how investigators using model systems (non-foveate animals, cell culture) can benefit from up-to-date information on human visual neuroscience, visual function, and retinal structure in aging and AMD.
Ocular Drug Delivery
Cost: MIT $49, Members $79, Nonmembers $109
Ocular drug delivery is an evolving field featuring cutting-edge advances in devices, formulations, and paradigms for design and characterization. This course will draw upon experts in the various disciplines of the field in order to instruct attendees on how to apply key concepts in drug delivery to improve upon the translational value of their research endeavors. Key topics will include fundamentals and pharmacokinetics of drug delivery to the anterior and posterior segment, anatomical and tissue barriers for ocular drug biodistribution, models for evaluating drug delivery systems, as well as advances in device, formulation, polymer, and lipid technologies, as well as regulatory and clinical considerations for incorporation of drug delivery technologies in the clinic.
Patient Data - Recognition, evaluation, incorporation and practice
Cost: MIT $49, Members $79, Nonmembers $109
Patient and public involvement (PPI) can be viewed as a means of increasing the impact, quality, and relevance of research studies. In what can often be a departure from conventional approaches, PPI describes research that is carried out ‘with’ or ‘by’ people living with sight loss rather than ‘to’, ‘about’ or ‘for’ them. This course provides practical guidance on why and how people living with sight loss can have a role in the development and execution of benchtop and clinical research studies. There will be a discussion of how patients and their caregivers can bring stakeholders together to address gaps in research, and the unique roles patients can play in prioritizing a research agenda – before and during clinical development.
On-demand webinars
Select the titles below to learn more and sign up. Visit ARVOLearn for access to more on-demand offerings.
Building drugs, devices, and novel therapeutics
Cost: Free
Hosted by the Women in Eye and Vision Research (WEAVR) Committee, this webinar explores topics relating to development of ophthalmic therapies, with applications of conventional drugs or devices, and novel biologic therapeutics. Each panelist also discusses their career journey, challenges and successes to give the audience a better understanding and appreciation of the scientific and regulatory process, and also provide insight for young scientists interested in a career in translational research or drug/device development.
COVID-19 one year later: Ethical issues in human subjects eye research when responding to a crisis
Cost: Free
The coronavirus SARS-COV-2 and its associated disease, COVID-19, have had profound global effects on the ability to continue scientific research involving human subjects. Investigators leading and participating in these studies need to manage new ethical, health and safety issues in the presence of this highly infectious and potentially fatal disease. Additionally, investigators must account for this major confounding factor when analyzing the research data.
This webinar explores:
- Varying responses to SARS-COV-2/COVID- 19 across the globe, and their impacts on the conduct of human research
- The ethical and safety issues specific to vision research and COVID-19
- How a major interruption or shutdown may impact experimental design and data analysis.
Gene therapies for inherited retinal diseases — Current outcomes and future impact
Cost: Free
ARVO and the American Academy of Ophthalmology (AAO) partnered to deliver this free webinar focused on genetic therapies for inherited retinal disorders. This webinar explores:
- The history of gene therapies for inherited retinal diseases
- Current and past uses of gene therapies
- The FDA approval process and clinical trials for gene therapies
- New technologies in gene editing
- Promising future therapies for inherited retinal diseases
Increasing the impact of your research — Social media, new metrics and beyond
Cost: Free
This event features talks from researchers at different career stages — from principal investigators to PhD students — detailing how they have successfully navigated the social media landscape to establish collaborations, gain media attention and expose their research to a broader community beyond scientific circles. Speakers also showcase how organizations and institutes can utilize social media to promote their researchers.
Integrating patient-reported outcomes in routine clinical practice
Cost: Free
Research in Patient-Reported Outcomes (PRO) measures has progressed a lot in the last 20 years. The use of PRO measures has become widespread with researchers seeking to understand the impact of disease and its treatment on patients. However, researchers have struggled to keep pace with developments in the field and still commonly use traditional methods such as summary scoring which does not enable valid interval scoring. This webinar will present a newer methodology (based on the latest science about PRO-measure usage) that improves the collection and assessment of PRO data.
International vision research in the 2020s
Cost: Free
There are over 39 million people around the world who are blind and an additional 246 million are not able to see properly. Eighty percent of blindness is considered preventable, however, a comprehensive research strategy and international research collaborations between the developed and developing world need to increase. Many of the reasons for causing blindness have been researched, but in several areas of the world a coordinated strategy for basic science and health services research is required to achieve reduction of the global burden of eye diseases and implementation of research findings. By attending this webinar, scientists and clinicians will be introduced to:
- New technologies and expanded research opportunities available to a large group of investigators
- New research databases for various eye diseases
- Strategies for international vision research collaboration at the global level
Preparing for partnering - Core competencies
Cost: Free
Partnerships between industry and academia are needed for successful translation of discoveries to clinical application. After attending this webinar, investigators interested in translational application of their discoveries will understand:
- How to protect intellectual property
- Derisk technologies to promote partnering with industry
- Preclinical toxiciology testing and testing geared towards regulatory filing
- Clinical testing and planning required for regulatory filing
- How to leverage resources around them to advance their technologies towards translational application